JERUSALEM, May 15, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company focused on inflammation and immunology, today announced that members of its leadership team will lead a strategic roundtable discussion at the 7th...
Hence then, the article about scinai immunotherapeutics to lead strategic roundtable discussion on oral therapies and the future of biologics at the 7th dermatology drug development summit europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe )
Also on site :
- Walmart Is Selling a 'Wonderful' Marc Jacobs Tote Bag for $74 Off, and It's the Perfect 'Roomy' Travel Bag
- Nordstrom Rack Has 'Stylish and 'Supportive' Sandals That You'll Want to Wear 'All Day' on Sale for 50% Off
- Bono & The Edge Join Claudia Sheinbaum at Street Child World Cup Event: ‘My President’